Anaptysbio (ANAB) EBT (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -184.20% |
| Dec 31, 2025 | 315.29% |
| Sep 30, 2025 | 139.16% |
| Jun 30, 2025 | 1.77% |
| Mar 31, 2025 | -79.15% |
| Dec 31, 2024 | 33.25% |
| Sep 30, 2024 | 29.58% |
| Jun 30, 2024 | -6.18% |
| Mar 31, 2024 | -136.20% |
| Dec 31, 2023 | 425.31% |
| Sep 30, 2023 | 6.37% |
| Jun 30, 2023 | 0.18% |
| Mar 31, 2023 | -80.33% |
| Dec 31, 2022 | 19.13% |
| Sep 30, 2022 | -2.54% |
| Jun 30, 2022 | 15.01% |
| Mar 31, 2022 | -1.02% |
| Dec 31, 2021 | -364.08% |
| Sep 30, 2021 | -1,461.54% |
| Jun 30, 2021 | 97.64% |
| Mar 31, 2021 | -153.99% |
| Dec 31, 2020 | 241.57% |
| Sep 30, 2020 | -10.30% |
| Jun 30, 2020 | -160.81% |
| Mar 31, 2020 | 59.27% |
| Dec 31, 2019 | 34.74% |
| Sep 30, 2019 | -29.40% |
| Jun 30, 2019 | -8.71% |
| Mar 31, 2019 | -28.58% |
| Dec 31, 2018 | -7.70% |
| Sep 30, 2018 | -17.18% |
| Jun 30, 2018 | 9.73% |
| Mar 31, 2018 | -123.63% |
| Dec 31, 2017 | 26.52% |
| Sep 30, 2017 | -238.41% |
| Jun 30, 2017 | 73.64% |
| Mar 31, 2017 | -213.36% |
| Dec 31, 2016 | -175.82% |
| Sep 30, 2016 | -153.00% |
| Jun 30, 2016 | 279.19% |